
Advancing NMOSD Care for Patients: Treatment Access, Education, and Holistic Well-Being
Recent advancements in neuromyelitis optica spectrum disorder (NMOSD) treatment have been shown in studies to significantly improve care for patients living with the rare autoimmune disease. FDA-approved therapies such as eculizumab (Soliris; Alexion), …